11 completed, 4 unknown, 3 terminated, 2 recruiting. 14 Phase 2, 8 Phase 1, 4 Phase 3, 1 Not applicable.
Follow Chondrosarcoma, Extraskeletal Myxoid: new trials by email Literature Review of Chondrosarcoma, Extraskeletal Myxoid trials Research Report on Chondrosarcoma, Extraskeletal Myxoid
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Radiological Diagnosis of Pediatric Neck Swellings Lipoma, Branchial Cleft Anomalies | Active not recruiting | Sohag University | 50 | 2026-02-20 | 2026-07-30 | |
| Evaluation of Chest CT Versus Chest X-Ray for Lung Surveillance After Curative-Intent Resection of High-Risk Truncal-Extremity Soft Tissue Sarcoma Biopsy, Chest Computed Tomography, Chest Radiography - Adult Pleomorphic Rhabdomyosarcoma, AJCC Grade 2 Sarcoma | Not applicable | Not yet recruiting | ECOG-ACRIN Cancer Research Group | 1582 | 2025-01-28 | 2024-07-30 |
| NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS) Surgical resection, Proton beam radiation therapy, Pazopanib - Adipocytic Neoplasm, Liposarcoma | Phase 1 / Phase 2 | Recruiting | St. Jude Children's Research Hospital | 139 | 2024-03-27 | 2026-08-03 |
| A Study to Assess the Safety and Tolerability of CFT8634 in Locally Advanced or Metastatic SMARCB1-Perturbed Cancers, Including Synovial Sarcoma and SMARCB1-Null Tumors CFT8634 - Synovial Sarcoma, Soft Tissue Sarcoma | Phase 1 | Terminated | C4 Therapeutics, Inc. | 49 | 2022-03-25 | 2024-12-17 |
| A Rollover Protocol to Allow for Continued Access to the LSD1 Inhibitor Seclidemstat (SP-2577) Seclidemstat - Ewing Sarcoma, Myxoid Liposarcoma | Phase 1 / Phase 2 | Unknown | Salarius Pharmaceuticals, LLC | 10 | 2022-01-15 | 2023-08-01 |
| Clinical Trial of SP-2577 (Seclidemstat) in Patients With Relapsed or Refractory Ewing or Ewing-related Sarcomas Seclidemstat, Cyclophosphamide, Topotecan - Ewing Sarcoma, Myxoid Liposarcoma | Phase 1 | Unknown | Salarius Pharmaceuticals, LLC | 50 | 2018-06-04 | 2023-11-21 |
| Trial of Sunitinib and/or Nivolumab Plus Chemotherapy in Advanced Soft Tissue and Bone Sarcomas Sunitinib 37.5 MG, Sunitinib 25 MG [Sutent], Nivolumab 100 MG/10 ML [Opdivo], Epirubicin - Soft Tissue Sarcoma, Bone Sarcoma | Phase 1 / Phase 2 | Completed | Grupo Espanol de Investigacion en Sarcomas | 197 | 2017-05-31 | 2024-08-13 |
| Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery Doxorubicin, Doxorubicin Hydrochloride, Ifosfamide - Alveolar Soft Part Sarcoma, Angiomatoid Fibrous Histiocytoma | Phase 2 / Phase 3 | Completed | National Cancer Institute (NCI) | 140 | 2014-08-12 | 2026-06-17 |
| Trial of Pazopanib in Patients With Solitary Fibrous Tumor and Extraskeletal Myxoid Chondrosarcoma Pazopanib - Solitary Fibrous Tumor, Extraskeletal Myxoid Chondrosarcoma | Phase 2 | Completed | Grupo Espanol de Investigacion en Sarcomas | 96 | 2014-06-01 | 2023-03-27 |
| Proton or Photon RT for Retroperitoneal Sarcomas IG-IMPT, IG IMRT - Retroperitoneal Sarcoma | Phase 1 / Phase 2 | Recruiting | Massachusetts General Hospital | 80 | 2012-12-01 | 2026-07-31 |
| Gemcitabine With or Without Pazopanib in Treating Patients With Refractory Soft Tissue Sarcoma Gemcitabine, Gemcitabine Hydrochloride, Laboratory Biomarker Analysis - Adult Alveolar Soft Part Sarcoma, Adult Angiosarcoma | Phase 2 | Completed | OHSU Knight Cancer Institute | 54 | 2012-03-13 | 2021-09-27 |
| Doxorubicin Hydrochloride or Trabectedin in Treating Patients With Previously Untreated Advanced or Metastatic Soft Tissue Sarcoma doxorubicin hydrochloride, trabectedin, laboratory biomarker analysis - Sarcoma | Phase 2 / Phase 3 | Terminated | European Organisation for Research and Treatment of Cancer - EORTC | 133 | 2011-05-01 | 2014-08-08 |
| Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic Sarcoma Gamma-Secretase Inhibitor RO4929097, Laboratory Biomarker Analysis, Pharmacological Study - Adult Alveolar Soft Part Sarcoma, Adult Angiosarcoma | Phase 1 / Phase 2 | Completed | National Cancer Institute (NCI) | 78 | 2010-06-01 | 2018-08-15 |
| Intensity-Modulated Radiation Therapy in Treating Patients Undergoing Surgery for Stage IB, Stage II, or Stage III Soft Tissue Sarcoma gene expression analysis, polymerase chain reaction, western blotting - Sarcoma | Phase 2 | Terminated | City of Hope Medical Center | 1 | 2008-07-01 | 2014-07-11 |
| Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma Cixutumumab, Doxorubicin Hydrochloride, Laboratory Biomarker Analysis - Adult Angiosarcoma, Adult Desmoplastic Small Round Cell Tumor | Phase 1 | Completed | National Cancer Institute (NCI) | 30 | 2008-06-01 | 2016-05-17 |
| Image-Guided Radiation Therapy in Treating Patients With Primary Soft Tissue Sarcoma of the Shoulder, Arm, Hip, or Leg Chemotherapy, Radiation therapy, Surgery - Lymphedema, Musculoskeletal Complications | Phase 2 | Completed | Radiation Therapy Oncology Group | 98 | 2008-03-01 | 2019-06-12 |
| Tissue Sample Collection From Patients With Soft Tissue Sarcoma of the Arms, Hands, Legs, or Feet Treated on Clinial Trial CRUK-VORTEX microarray analysis, molecular diagnostic method, biologic sample preservation procedure - Sarcoma | Unknown | The Christie NHS Foundation Trust | 400 | 2007-08-01 | 2013-08-26 | |
| Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas sunitinib malate - Adult Malignant Fibrous Histiocytoma of Bone, Desmoid Tumor | Phase 2 | Completed | Memorial Sloan Kettering Cancer Center | 53 | 2007-04-01 | 2016-01-20 |
| Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma doxorubicin hydrochloride, clinical observation, therapeutic conventional surgery - Adult Alveolar Soft-part Sarcoma, Adult Angiosarcoma | Phase 3 | Completed | Children's Oncology Group | 588 | 2007-02-05 | 2022-04-28 |
| Randomised Trial of Volume of Post-operative Radiotherapy Given to Adult Patients With eXtremity Soft Tissue Sarcoma radiotherapy - Sarcoma | Phase 3 | Completed | Sheffield Teaching Hospitals NHS Foundation Trust | 216 | 2006-03-01 | 2021-03-18 |
Showing 20 of 22. Sign in to see all of them.
Sarcoma (18) · Sarcoma, Synovial (15) · Fibrosarcoma (14) · Histiocytoma, Malignant Fibrous (14) · Leiomyosarcoma (14) · Neurofibrosarcoma (14) · Hemangiosarcoma (13) · Liposarcoma (12) · Sarcoma, Alveolar Soft Part (12) · Malignant mesenchymal tumor (10) · Hemangiopericytoma, Malignant (9) · Dermatofibrosarcoma (8) · Rhabdomyosarcoma (8) · Desmoplastic Small Round Cell Tumor (7)
Neoplasms (21) · Neoplasms by Histologic Type (21) · Neoplasms, Connective and Soft Tissue (21) · Neoplasms, Connective Tissue (19) · Neoplasms, Fibrous Tissue (17) · Neoplasms, Muscle Tissue (16) · Histiocytoma (14) · Neoplasms, Adipose Tissue (14) · Neoplasms, Nerve Tissue (14) · Neoplasms, Vascular Tissue (14) · Nervous System Diseases (14) · Nervous System Neoplasms (14) · Neurofibroma (14) · Neuromuscular Diseases (14) · Peripheral Nervous System Diseases (14)
Doxorubicin (6) · Ifosfamide (4) · pazopanib (4) · Radiotherapy (3) · Cyclophosphamide (2) · Sunitinib (2) · Topotecan (2) · seclidemstat (2) · 2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide (1) · Biopsy (1) · Blotting, Western (1) · Cisplatin (1) · Dacarbazine (1) · Drug Therapy (1) · Epirubicin (1)
National Cancer Institute (NCI) (4) · Grupo Espanol de Investigacion en Sarcomas (2) · Salarius Pharmaceuticals, LLC (2) · C4 Therapeutics, Inc. (1) · Children's Oncology Group (1) · City of Hope Medical Center (1) · ECOG-ACRIN Cancer Research Group (1) · European Organisation for Research and Treatment of Cancer - EORTC (1) · Herbert Irving Comprehensive Cancer Center (1) · Massachusetts General Hospital (1) · Memorial Sloan Kettering Cancer Center (1) · OHSU Knight Cancer Institute (1) · Radiation Therapy Oncology Group (1) · Sheffield Teaching Hospitals NHS Foundation Trust (1) · Sohag University (1)
United States (15) · United Kingdom (4) · Canada (3) · Spain (3) · Puerto Rico (2) · Australia (1) · Austria (1) · Belgium (1) · Denmark (1) · Egypt (1) · France (1) · Germany (1) · Hungary (1) · Italy (1) · Netherlands (1)
Aaron R Weiss (1) · Alba Rubio (1) · Antonio Casado (1) · Burton L. Eisenberg, MD (1) · Catherine West (1) · Christopher W Ryan (1) · Claudia Valverde (1) · Cristina Mata (1) · David G. Kirsch, MD, PhD (1) · Dian Wang, MD, PhD (1)
PMID 31401903, PMID 19451429, PMID 25667281, PMID 25858498, PMID 28391003, PMID 30578023, PMID 30954717, PMID 31331701, PMID 31786124, PMID 32066540, PMID 32702309, PMID 32827353, PMID 33203665, PMID 33548339, PMID 34515544, PMID 34623899, PMID 35965642, PMID 36566574, PMID 36995690, PMID 37523624, PMID 38757485, PMID 39122389, PMID 39356980, PMID 41386267, PMID 41836677
P30CA008748 (2), U10CA098543 (2), 2009 (1), N01CM00071 (1), N01CM62206 (1), P30CA012197 (1), P30CA014599 (1), P30CA033572 (1), U01CA069856 (1), U10CA081851 (1), U10CA180830 (1), U10CA180886 (1), UG1CA189828 (1)